PARIS, October 28, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for the third quarter of 2016. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the results.
Watch video interview and read transcript:
https://www.eurobusinessmedia.com/video/sanofi-q3-2016-results/?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- Q3 highlights
- Cost savings
- Diabetes
- Capital allocation
- Portfolio
- Dengvaxia(R)
- Outlook
About Sanofi:
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Share this article